Hepatology Research Group
Dedicated to improving the understanding and treatment of liver disease

Plymouth is now an active recruitment site part of the national MRC funded consortium aiming to minimise death from alcoholic hepatitis (MICAH). Led by Dr Ashwin Dhanda the group is validating a novel bioassay to measure response to glucocorticoid (steroid) therapy.
"Liver disease has become one of the most common causes of premature death in the UK, with a cost not just in lives but also to health services and society."
The University of Plymouth’s flagship medical research instituteState-of-the-art headquarters of the Plymouth Institute of Health and Care Research